This report offers companies, investors, policymakers, and stakeholders crucial insight into France; a country at the forefront of innovation, creativity and new trends in the pharmaceutical and healthcare industries. With some of the strictest legislation in Europe, French firms must be the very best in order to bring new innovations to market, helping to make France a world leader in R&D and clinical trials.

The report features in-depth exclusive interviews with leading figures from public institutions and private companies, comprehensive articles, and up-to-date facts and figures on the French healthcare and pharma sectors.